EGFR 1.46% 2.63% 1.33% ERBB2 1.94% 0.88% 2.00% ERBB3 0.97% 1.33% ERBB4 0.88% 4.00% MET 1.46% 2.63% 3.33% PDGFRA 1.46% 1.75% 2.67% FGFR1 4.37% 7.89% 6.00% FGFR2 0.49% 0.88% FGFR3 1.46% 1.33% FGFR4 2.43% 2.67% KIT 0.49% 0.88% 3.33% IGF1R 0.88% 2.67% JAK2 0.97% 2.63% 2.67% RET 3.40% 0.88% 4.67% ROS1 12.62% 5.26% 6.67% ALK 1.94% 1.75% 2.67% FLT3 0.97% 2.67% NTRK1 0.97% 5.26% 2.00% NTRK2 0.49% 0.88% 0.67% NTRK3 1.46% 3.51% 1.33% CBL 1.94% 2.63% 1.33% ABL1 1.94% 1.75% 2.00% SOS1 0.97% 1.75% 1.33% NF1 0.97% 2.63% 2.00% RASA1 6.80% 5.26% 2.67% PTPN11 1.46% KRAS 2.43% 3.51% 2.67% HRAS 1.94% 1.75% 2.00% NRAS 1.46% 1.75% RIT1 0.49% 2.63% 4.67% ARAF 3.33% BRAF 1.94% 0.88% 3.33% RAF1 1.46% 2.00% MAP2K2 0.97% 0.88% 1.33% MAPK1 0.49% 1.33% RAC1 0.97% 1.75% Cell survivalTranslationProliferationRAS/RAF pathway CPGEA TCGA SU2C Alteration frequencies Oncogene <1% >1% >5% >10% Tumor Suppressor <1% >1% >5% >10% Note: Click gene name to see detailed information.
Copyright © Department of Urology, Changhai Hospital & Center for Translational Medicine. All rights reserved.